474 related articles for article (PubMed ID: 21977033)
21. The Fundamental Contribution of Judah Folkman in the Setting of Angiogenesis Assays.
Ribatti D
Methods Mol Biol; 2021; 2206():15-25. PubMed ID: 32754807
[TBL] [Abstract][Full Text] [Related]
22. Use of lipid-based nutrient supplements (LNS) to improve the nutrient adequacy of general food distribution rations for vulnerable sub-groups in emergency settings.
Chaparro CM; Dewey KG
Matern Child Nutr; 2010 Jan; 6 Suppl 1(Suppl 1):1-69. PubMed ID: 20055936
[TBL] [Abstract][Full Text] [Related]
23. Angiogenesis and breast cancer.
Hayes DF
Hematol Oncol Clin North Am; 1994 Feb; 8(1):51-71. PubMed ID: 7512088
[TBL] [Abstract][Full Text] [Related]
24. Targeting of the breast cancer microenvironment with a potent and linkable oxindole based antiangiogenic small molecule.
Argyros O; Karampelas T; Varela A; Asvos X; Papakyriakou A; Agalou A; Beis D; Davos CH; Fokas D; Tamvakopoulos C
Oncotarget; 2017 Jun; 8(23):37250-37262. PubMed ID: 28422745
[TBL] [Abstract][Full Text] [Related]
25. Angiogenesis inhibitors: perspectives for medical, surgical and radiation oncology.
Verhoef C; de Wilt JH; Verheul HM
Curr Pharm Des; 2006; 12(21):2623-30. PubMed ID: 16842162
[TBL] [Abstract][Full Text] [Related]
26. Neovastat, a naturally occurring multifunctional antiangiogenic drug, in phase III clinical trials.
Falardeau P; Champagne P; Poyet P; Hariton C; Dupont E
Semin Oncol; 2001 Dec; 28(6):620-5. PubMed ID: 11740820
[TBL] [Abstract][Full Text] [Related]
27. [Application of bevacizumab on metastatic breast cancer].
Guo Yt; Ding L; Li Th
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):708-14. PubMed ID: 23073579
[TBL] [Abstract][Full Text] [Related]
28. Commentary on Folkman: "How Is Blood Vessel Growth Regulated in Normal and Neoplastic Tissue?".
Augustin HG
Cancer Res; 2016 May; 76(10):2854-6. PubMed ID: 27197228
[TBL] [Abstract][Full Text] [Related]
29. Angiogenesis and cancer: from basic mechanisms to therapeutic applications.
Fernandez PM
Drug News Perspect; 2000 Nov; 13(9):567-76. PubMed ID: 12879128
[TBL] [Abstract][Full Text] [Related]
30. Vascular integrins in tumor angiogenesis: mediators and therapeutic targets.
Alghisi GC; Rüegg C
Endothelium; 2006; 13(2):113-35. PubMed ID: 16728329
[TBL] [Abstract][Full Text] [Related]
31. Combination of antiangiogenesis with chemotherapy for more effective cancer treatment.
Ma J; Waxman DJ
Mol Cancer Ther; 2008 Dec; 7(12):3670-84. PubMed ID: 19074844
[TBL] [Abstract][Full Text] [Related]
32. Diet and cancer: the disconnect between epidemiology and randomized clinical trials.
Meyskens FL; Szabo E
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1366-9. PubMed ID: 15941942
[TBL] [Abstract][Full Text] [Related]
33. Thalidomide and immunomodulatory drugs as cancer therapy.
Raje N; Anderson KC
Curr Opin Oncol; 2002 Nov; 14(6):635-40. PubMed ID: 12409654
[TBL] [Abstract][Full Text] [Related]
34. [SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].
Zona A; Fazzo L; Benedetti M; Bruno C; Vecchi S; Pasetto R; Minichilli F; De Santis M; Nannavecchia AM; Di Fonzo D; Contiero P; Ricci P; Bisceglia L; Manno V; Minelli G; Santoro M; Gorini F; Ancona C; Scondotto S; Soggiu ME; Scaini F; Beccaloni E; Marsili D; Villa MF; Maifredi G; Magoni M; Iavarone I;
Epidemiol Prev; 2023; 47(1-2 Suppl 1):1-286. PubMed ID: 36825373
[TBL] [Abstract][Full Text] [Related]
35. The importance of antiangiogenic effect in multiple myeloma treatment.
Barchnicka A; Olejniczak-Nowakowska M; Krupa-Kotara K; Grosicki S
Adv Clin Exp Med; 2018 Feb; 27(2):291-297. PubMed ID: 29521075
[TBL] [Abstract][Full Text] [Related]
36. Antiangiogenic therapy in hematologic malignancies.
Moehler TM; Hillengass J; Goldschmidt H; Ho AD
Curr Pharm Des; 2004; 10(11):1221-34. PubMed ID: 15078137
[TBL] [Abstract][Full Text] [Related]
37. Targeting angiogenesis in advanced breast cancer.
Zelnak AB; O'Regan RM
BioDrugs; 2007; 21(4):209-14. PubMed ID: 17628118
[TBL] [Abstract][Full Text] [Related]
38. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
Kerbel RS
Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
